CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology

References

• Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD (1998). Differential expression of inflammatory cytokines par-allels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J Immunol 161: 4437–4446.
   PubMedGoogle Scholar
• Borrow P, Welsh CJ, Nash AA (1993). Study of the mech-anisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis. Immunology 80: 502–506.
   Google Scholar
• Carter L, Dutton RW (1996). Type 1 and type 2: A functional dichotomy for all T cell subsets. Curr Opin Immunol 8: 336–342.
   PubMed Web of Science ®Google Scholar
• Clatch RJ, Lipton HL, Miller SD (1986). Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. Jimmunol 136: 920–927.
   PubMed Web of Science ®Google Scholar
• Clatch RJ, Melvold RW, Miller SD, Lipton HL (1985). Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: Correlation with TMEV-specific delayed-type hypersensitivity. I Immunol 135: 1408–1414.
   PubMed Web of Science ®Google Scholar
• Croft M, Carter L, Swain SL, Dutton RW (1994). Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in pro-moting type 2 versus type 1 cytokine profiles. J Exp Med 180: 1715–1728.
   PubMed Web of Science ®Google Scholar
• Dethlefs S, Brahic M, Larsson-Sciard EL (1997). An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence. I Virol 71: 8875–8878.
   Google Scholar
• Fiette L, Aubert C, Brahic M, Pena Rossi C (1993). Theiler's virus infection of, 82-microglobulin-deficient mice. I Virol 67: 589–592.
   Google Scholar
• Friedmann A, Fr ankel G, Lorch Y, Steinman L (1987). Mono-clonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: Critical importance of timing of treatment. I Virol 61: 898–903.
   Google Scholar
• Gerety SJ, Rundell MK, Dal Canto MC, Miller SD (1994). Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinat-ing disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. J Immunol 152: 919–929.
   Google Scholar
• Graves MC, Bologa L, Siegel L, Londe H (1986). Theiler's virus in brain cell cultures: Lysis of neurons and oligodendrocytes and persistence in astrocytes and macrophages. I Neurosci Res 15: 491–501.
   Google Scholar
• Haynes LM, Vanderlugt CL, Dal Canto MC, Melvold RW, Miller SD (2000). CD8 + T cells from Theiler's virus- resistant BALB/ cByJ mice downregulate pathogenic virus-specific CD4+ T cells. I Neuroimmunol 106: 43–52.
   Google Scholar
• Inoue A, Koh CS, Yamazaki M, Yahikozawa H, Ichikawa H, Yagita H, Kim BS (1998). Suppressive effect on Theiler's murine encephalomyelitis virus-induced demyelinating disease by the administration of anti-IL-12 antibody. J Immunol 161: 5586–5593.
   Google Scholar
• Kappel CA, Dal Canto MC, Melvold RW, Kim BS (1991). Hierarchy of effects of the MHC and T cell receptor beta-chain genes in susceptibility to Theiler's murine en-cephalomyelitis virus-induced demyelinating disease. J Immunol 147: 4322–4326.
   Google Scholar
• Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD (1995). Inhibition of Theiler's virus-mediated de-myelination by peripheral immune tolerance induction. J Immunol 155: 947–957.
   PubMed Web of Science ®Google Scholar
• Koller B, Marrack P, Kappler J, Smithies 0 (1990). Nor-mal development of mice deficient in, 82-microglobulin, MHC class I proteins and CD8 + T cells. Science 248: 1227–1230.
   Google Scholar
• Kurtzke JF (1993). Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6: 382–427.
   PubMed Web of Science ®Google Scholar
• Larsson-Sciard EL, Dethlefs S, Brahic M (1997). In vivo ad-ministration of interleukin-2 protects susceptible mice from Theiler's virus persistence. I Virol 71: 797–799.
   Google Scholar
• Lavi E, Das Sarma J, Weiss SR (1999). Cellular reservoirs for coronavirus infection of the brain in, 82-microglobulin knockout mice. Path obiology 67: 75–83.
   Google Scholar
• Li L, Sad S, Kagi D, Mosmann TR (1997). CD8 Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J Immunol 158: 4152–4161.
   Google Scholar
• Lin X, Thiemann NR, Pease LR, Rodriguez M (1995). VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214: 91–99.
   Google Scholar
• Lindsley MD, Thiemann R, Rodriguez M (1991). Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. I Virol 65: 6612–6620.
   Google Scholar
• Lipton HL, Dal Canto MC (1979). Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun 26: 369–374.
   Google Scholar
• Lipton HL, Gonzalez-Scarano F (1978). Central nervous system immunity in mice infected with Theiler's virus. I. Local neutralizing antibody response. I Infect Dis 137: 145–151.
   Google Scholar
• Lipton HL, Kratochvil J, Sethi P, Dal Canto MC (1984). Theiler's virus antigen detected in mouse spinal cord 24 years after infection. Neurology 34: 1117–1119.
   Google Scholar
• Matloubian M, Concepcion RJ, Ahmed R (1994). CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. I Virol 68: 8056–8063.
   PubMed Web of Science ®Google Scholar
• Miller SD, Karpus WJ (1994). The immunopathogenesis and regulation of T-cell mediated demyelinating dis-eases. Immunol Today 15: 356–361.
   PubMedGoogle Scholar
• Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS (1997). Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 3: 1133–1136.
   PubMed Web of Science ®Google Scholar
• Murray PD, Pavelko KD, Leibowitz J, Lin X, Rodriguez M (1998). CD4+ and CD8+ T cells make discrete contribu-tions to demyelination and neurologic disease in a viral model of multiple sclerosis. I Virol 72: 7320–7329.
   Google Scholar
• Nicholson SM, Dal Canto MC, Miller SD, Melvold RW (1996). Adoptively transferred CD8+ lymphocytes pro-vide protection against TMEV-induced demyelinating disease in BALB/c mice. J Immunol 156: 1276–1283.
   Google Scholar
• Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Leibowitz J, Rodriguez M (1996). Theiler's virus per-sistence and demyelination in major histocompatibility complex class II-deficient mice. I Virol 70: 1729–1737.
   Google Scholar
• Ohara Y, Konno H, Iwasaki Y, Yamamoto T, Terunuma H, Suzuki H (1990). Cytotropism of Theiler's murine encephalomyelitis viruses in oligodendrocyte -enriched cultures. Arch Virol 114: 293–298.
   Google Scholar
• Pena Rossi C, McAllister A, Fiette L, Brahic M (1991). Theiler's virus infection induces a specific cytotoxic T lymphocyte response. Cell Immunol 138: 341–348.
   Google Scholar
• Pena-Rossi C, McAllister A, Tanguy M, Kagi D, Brahic M (1998). Theiler's virus infection of perforin-deficient mice. I Virol 72: 4515–4519.
   Google Scholar
• Peterson JD, Karpus WJ, Clatch RJ, Miller SD (1993). Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur J. Immunol 23: 46–55.
   Google Scholar
• Pope JG, Karpus WJ, Vanderlugt CL, Miller SD (1996). Flow cytometric and functional analyses of CNS-infiltrating cells in SJL/J mice with Theiler's virus-induced demye-linating disease: Evidence for a CD4+ T cell-mediated pathology. J Immunol 156: 4050–4058.
   Google Scholar
• Pullen LC, Miller SD, Dal Canto MC, Kim BS (1993). Class I-deficient re sis tant mice intracerebrally inoculate d with Theiler's virus show an increased T cell response to vi-ral antigens and susceptibility to demyelination. Eur I Immunol 23: 2287–2293.
   Google Scholar
• Rivera-Quinones C, McGavernD, Schmelzer JD, Hunter SF, Low PA, Rodriguez M (1998). Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med 4: 187–193.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, David CS (1985). Demyelination induced by Theiler's virus: Influence of the H-2 haplotype. I Im-munol 135: 2145–2148.
   Google Scholar
• Rodriguez M, Dunkel AJ, Thiemann RL, Leibowitz J, Zijlstra M, Jaenisch R (1993). Abrogation of resistance to Theiler's virus-induced demyelination in H-21 mice deficient in /32-microglobulin. I Immunol 151: 266–276.
   Google Scholar
• Rodriguez M, Lafuse WP, Leibowitz J, David CS (1986a). Partial suppression of Theiler's virus-induced demyeli-nation in vivo by administration of monoclonal anti-bodies to immune-response gene products (Ia antigens). Neurology 36: 964–970.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Leibowitz J, David CS (1986b). Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. I Exp Med 163: 620–631.
   Google Scholar
• Rodriguez M, Leibowitz JL, Lampert PW (1983). Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol 13: 426–433.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Siegel LM, Hovanec-Burns D, Bologa L, Graves MC (1988). Theiler's virus-associated antigens on the surfaces of cultured glial cells. Virology 166: 463–474.
   Google Scholar
• Rodriguez M, Sriram S (1988). Successful therapy of Theiler's virus-induced demyelination (DA Strain) with monoclonal anti-Lyt-2 antibody. I Immunol 140: 2950–2955.
   PubMed Web of Science ®Google Scholar
• Sad S, Marcotte R, Mosmann TR (1995). Cytokine-induced differentiation of precursor mouse CD8+ T cells into cy-totoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2: 271–279.
   PubMed Web of Science ®Google Scholar
• Sad S, Mosmann TR (1995). Interleukin (IL) 4, in the ab-sence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: Loss of IL-2 syn-thesis and autonomous proliferation but retention of cy-totoxicity and synthesis of other cytokines. I Exp Med 182: 1505–1515.
   PubMed Web of Science ®Google Scholar
• Seder RA, Le Gros G (1995). The functional role of CD8+ T helper type 2 cells (comment). J Exp Med 181: 5–7. Waksman BH (1995). Multiple sclerosis:More genes versus environment. Nature 377: 105–106.
   Google Scholar
• Welsh CJ, Tonks P, Nash AA, Blakemore WF (1987). The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. I Gen Virol 68: 1659–1667.
   PubMed Web of Science ®Google Scholar
• Yauch RL, Palma JP, Yahikozawa H, Koh CS, Kim BS (1998). Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. I Virol 72: 6169–6174.
   Google Scholar
• Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R (1990). Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344: 742–746.
   PubMed Web of Science ®Google Scholar